Revance Therapeutics Inc. buy michaelkr
Start price
09.12.24
/
50%
€3.66
Target price
09.12.25
-
Performance (%)
-19.67%
End price
22.12.24
€2.94
Summary
This prediction ended on 22.12.24 with a price of €2.94. The price of Revance Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.67%. michaelkr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by michaelkr for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.